Emre Can Akinsal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emre Can Akinsal has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Numan Baydilli
Department of Pediatric Urology, Erciyes University Faculty of Medicine, Kayseri, Turkey
16 shared publications - Halil Tosun
Department of Pediatric Urology, Faculty of Medicine, Erciyes University, 38280 Kayseri, Türkiye
8 shared publications - Gökhan Sönmez
Department of Urology, Erciyes University Faculty of Medicine, Kayseri, Turkey
6 shared publications N. Baydilli
Urology Department, Medical Faculty, Erciyes University, Kayseri, Turkey
6 shared publications- Oğuz Ekmekçioğlu
Department of Urology, Erciyes University School of Medicine, Kayseri, Turkey
6 shared publications D. Demirci
4 shared publications
Latest Publications
- Open Access
- 19 November 2025
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 32 (3) , 249-254
https://www.dirjournal.org/articles/evaluation-of-the-congenital-absence-of-the-vas-deferens-with-magnetic-resonance-imaging-preliminary-findings/doi/dir.2025.253612
Evaluation of the congenital absence of the vas deferens with magnetic resonance imaging: preliminary findings - Diagnostic and Interventional Radiology
- 19 November 2025
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 32 (3) , 249-254
Open Accesshttps://www.dirjournal.org/articles/evaluation-of-the-congenital-absence-of-the-vas-deferens-with-magnetic-resonance-imaging-preliminary-findings/doi/dir.2025.253612
Evaluation of the congenital absence of the vas deferens with magnetic resonance imaging: preliminary findings - Diagnostic and Interventional Radiology
- 29 October 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (1) , 162780
Outcomes of mini-percutaneous nephrolithotomy in pediatric patients with spinal deformities: A controlled comparative study
- 29 October 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (1) , 162780
Outcomes of mini-percutaneous nephrolithotomy in pediatric patients with spinal deformities: A controlled comparative study
- 11 September 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (12) , 162663
A Comparative Study of Neural and Connective Tissue Markers in Pediatric and Adult Cases With Ureteropelvic Junction Obstruction
- 11 September 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (12) , 162663
A Comparative Study of Neural and Connective Tissue Markers in Pediatric and Adult Cases With Ureteropelvic Junction Obstruction
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 1309-1315
Evaluating the Efficacy of High-Intensity Focused Electromagnetic (HIFEM) Therapy for Postprostatectomy Incontinence in Men
Purpose: Urinary incontinence (UI) is a common complication after radical prostatectomy (RP), adversely affecting patients’ quality of life. This study aimed to evaluate the efficacy and safety of high-intensity focused electromagnetic (HIFEM) therapy as a non-invasive treatment for post-prostatectomy UI. Patients and Methods: Twenty-seven men (mean age ± SD: 67.9 ± 3.4 years) with persistent UI after RP underwent six HIFEM sessions (28 min, twice weekly) using the BTL EMSELLA® chair. Outcomes were assessed after the sixth session and at one-month follow-up. Primary endpoints were changes in International Consultation on Incontinence Questionnaire–Short Form (ICIQ-SF) scores and daily pad use. Results: Baseline mean ICIQ-SF score was 10.58 ± 4.15. This decreased to 5.43 ± 3.85 after treatment and to 4.16 ± 3.97 at one month, representing improvements of 53.1% and 60.6%, respectively (both p < 0.005). Daily pad use declined from baseline to 1.45 ± 1.54 after treatment and 1.13 ± 1.81 at follow-up (both p < 0.001). No adverse events were reported. Conclusion: HIFEM therapy significantly improved UI severity and reduced pad dependence in men with post-prostatectomy incontinence, with effects sustained for at least one month and no observed side effects. These findings support HIFEM as a safe, non-invasive treatment option warranting further study in larger, long-term trials.
- 1 August 2025
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 21, 1309-1315
Open AccessEvaluating the Efficacy of High-Intensity Focused Electromagnetic (HIFEM) Therapy for Postprostatectomy Incontinence in Men
Purpose: Urinary incontinence (UI) is a common complication after radical prostatectomy (RP), adversely affecting patients’ quality of life. This study aimed to evaluate the efficacy and safety of high-intensity focused electromagnetic (HIFEM) therapy as a non-invasive treatment for post-prostatectomy UI. Patients and Methods: Twenty-seven men (mean age ± SD: 67.9 ± 3.4 years) with persistent UI after RP underwent six HIFEM sessions (28 min, twice weekly) using the BTL EMSELLA® chair. Outcomes were assessed after the sixth session and at one-month follow-up. Primary endpoints were changes in International Consultation on Incontinence Questionnaire–Short Form (ICIQ-SF) scores and daily pad use. Results: Baseline mean ICIQ-SF score was 10.58 ± 4.15. This decreased to 5.43 ± 3.85 after treatment and to 4.16 ± 3.97 at one month, representing improvements of 53.1% and 60.6%, respectively (both p < 0.005). Daily pad use declined from baseline to 1.45 ± 1.54 after treatment and 1.13 ± 1.81 at follow-up (both p < 0.001). No adverse events were reported. Conclusion: HIFEM therapy significantly improved UI severity and reduced pad dependence in men with post-prostatectomy incontinence, with effects sustained for at least one month and no observed side effects. These findings support HIFEM as a safe, non-invasive treatment option warranting further study in larger, long-term trials.
- 1 January 2025
- Vol. 22 (1) , 44-49
Sexual Functions in Men with Congenital Bilateral Absence of the Vas Deferens: A Retrospective Cross-sectional Study with Fertile Men
Purpose: To examine the sexual and psychological conditions of men with Bilateral Congenital Bilateral Absence of the Vas Deferens (CBAVD), a rare condition that contributes to male infertility, and compare it with healthy fertile men. Material and Methods: A total of 52 patients with CBAVD and 66 healthy, fertile men who attended our infertility and andrology clinic were included in the study. Patients with cognitive impairments, language barriers, significant comorbidities, or a history of urogenital surgery were excluded. Reproductive hormone levels and semen volumes were evaluated. In addition, sexual status was investigated with validated questionnaires such as the International Index of Erectile Function, Male Sexual Health Questionnaire, Arabic Index of Premature Ejaculation, Premature Ejaculation Diagnostic Tool, and Premature Ejaculation Profile. Results: In the CBAVD group, median total testosterone, FSH, LH levels, and semen volume were 401 ng/dL, 3.9 mIU/ml, 3.9 mIU/ml, and 0.9 ml, respectively. These parameters were 376 (ng/dL), 4.8 mIU/ml, 5 mIU/ml, and 3 ml in the control group. Semen volume was significantly lower in CBAVD men (p < 0.001). Questionnaires assessing erectile and ejaculatory function have shown that there was no significant difference between the CBAVD and control groups in terms of erectile function, orgasmic function, and sexual relationship satisfaction. However, sexual desire (p = 0.006) and overall satisfaction (p = 0.028) were found to be higher in the CBAVD group. Conclusion: The study suggests that CBAVD may not be a direct etiological factor for erectile dysfunction or premature ejaculation.
- 1 January 2025
- Vol. 22 (1) , 44-49
Sexual Functions in Men with Congenital Bilateral Absence of the Vas Deferens: A Retrospective Cross-sectional Study with Fertile Men
Purpose: To examine the sexual and psychological conditions of men with Bilateral Congenital Bilateral Absence of the Vas Deferens (CBAVD), a rare condition that contributes to male infertility, and compare it with healthy fertile men. Material and Methods: A total of 52 patients with CBAVD and 66 healthy, fertile men who attended our infertility and andrology clinic were included in the study. Patients with cognitive impairments, language barriers, significant comorbidities, or a history of urogenital surgery were excluded. Reproductive hormone levels and semen volumes were evaluated. In addition, sexual status was investigated with validated questionnaires such as the International Index of Erectile Function, Male Sexual Health Questionnaire, Arabic Index of Premature Ejaculation, Premature Ejaculation Diagnostic Tool, and Premature Ejaculation Profile. Results: In the CBAVD group, median total testosterone, FSH, LH levels, and semen volume were 401 ng/dL, 3.9 mIU/ml, 3.9 mIU/ml, and 0.9 ml, respectively. These parameters were 376 (ng/dL), 4.8 mIU/ml, 5 mIU/ml, and 3 ml in the control group. Semen volume was significantly lower in CBAVD men (p < 0.001). Questionnaires assessing erectile and ejaculatory function have shown that there was no significant difference between the CBAVD and control groups in terms of erectile function, orgasmic function, and sexual relationship satisfaction. However, sexual desire (p = 0.006) and overall satisfaction (p = 0.028) were found to be higher in the CBAVD group. Conclusion: The study suggests that CBAVD may not be a direct etiological factor for erectile dysfunction or premature ejaculation.
- Open Access
- 1 November 2024
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 20, 811-816
Is the High-Intensity Focused Electromagnetic Energy an Effective Treatment for Urinary Incontinence in Women?
Purpose: To assess the effectiveness and safety of high-intensity focused electromagnetic technology (HIFEM) used as a therapeutic approach in patients with stress and mixed urinary incontinence. Patients and Methods: Thirty-five females suffering from stress and mixed urinary incontinence were included in the study. The electromagnetic chair (BTL EMSELLA®) was applied to the patient’s pelvic area twice a week for 28 minutes, totaling 6 sessions. The patients’ “International Consultation on Incontinence Questionnaire‐Short Form” (ICIQ-SF) scores and the number of daily absorbent pad usage were recorded. Results were evaluated after the sixth session and at a first-month follow-up. Results: The average ICIQ‐SF score at baseline was 10.18 ± 4.19 (ranging from 2– 18) which declined to 5.33 ± 3.97 after six sessions, and further improved to 4.26 ± 3.94 points at the one‐month follow‐up. After six sessions, an average improvement of 52.06% in ICIQ-SF score was observed, and after one month of follow-up, an average improvement of 59.6% was detected, which was found to be statistically significant (p=0.038). In addition, the mean number of pads used per day decreased to 1.25 ± 1.54 after treatment, a significant improvement was observed, and the mean daily pad use decreased further to 0.91 ± 1.11 at the first-month follow-up. Conclusion: HIFEM has demonstrated in our study its ability to safely and effectively treat female patients suffering from stress and mixed urinary incontinence, as evidenced by significant improvements in symptoms and quality of life observed in clinical trials.
- 1 November 2024
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 20, 811-816
Open AccessIs the High-Intensity Focused Electromagnetic Energy an Effective Treatment for Urinary Incontinence in Women?
Purpose: To assess the effectiveness and safety of high-intensity focused electromagnetic technology (HIFEM) used as a therapeutic approach in patients with stress and mixed urinary incontinence. Patients and Methods: Thirty-five females suffering from stress and mixed urinary incontinence were included in the study. The electromagnetic chair (BTL EMSELLA®) was applied to the patient’s pelvic area twice a week for 28 minutes, totaling 6 sessions. The patients’ “International Consultation on Incontinence Questionnaire‐Short Form” (ICIQ-SF) scores and the number of daily absorbent pad usage were recorded. Results were evaluated after the sixth session and at a first-month follow-up. Results: The average ICIQ‐SF score at baseline was 10.18 ± 4.19 (ranging from 2– 18) which declined to 5.33 ± 3.97 after six sessions, and further improved to 4.26 ± 3.94 points at the one‐month follow‐up. After six sessions, an average improvement of 52.06% in ICIQ-SF score was observed, and after one month of follow-up, an average improvement of 59.6% was detected, which was found to be statistically significant (p=0.038). In addition, the mean number of pads used per day decreased to 1.25 ± 1.54 after treatment, a significant improvement was observed, and the mean daily pad use decreased further to 0.91 ± 1.11 at the first-month follow-up. Conclusion: HIFEM has demonstrated in our study its ability to safely and effectively treat female patients suffering from stress and mixed urinary incontinence, as evidenced by significant improvements in symptoms and quality of life observed in clinical trials.
- Open Access
- 9 July 2024
- Published by Elsevier in Prostate International
- Vol. 12 (3) , 155-159
Does the type of the previous biopsy affect the fusion prostate biopsy results?
- 9 July 2024
- Published by Elsevier in Prostate International
- Vol. 12 (3) , 155-159
Open AccessDoes the type of the previous biopsy affect the fusion prostate biopsy results?
- Open Access
- 1 January 2023
- Published by Turk Androloji Dernegi in Androloji Bülteni
Hematospermili hastaya yaklaşım
- 1 January 2023
- Published by Turk Androloji Dernegi in Androloji Bülteni
Open AccessHematospermili hastaya yaklaşım
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 68.e1-68.e8
Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 68.e1-68.e8
Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux
- Open Access
- 1 January 2021
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 47 (3) , 248-249
Micro-ureteroscopy (m-URS) for treatment of upper ureteral stones in children: A new, different approach
Cite this article as: Baydilli N, Selvi İ, Akınsal EC, Demirci D. Micro-ureteroscopy (m-URS) for treatment of upper ureteral stones in children: A new, different approach. Turk J Urol 2021; 47(3): 248-9.
- 1 January 2021
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 47 (3) , 248-249
Open AccessMicro-ureteroscopy (m-URS) for treatment of upper ureteral stones in children: A new, different approach
Cite this article as: Baydilli N, Selvi İ, Akınsal EC, Demirci D. Micro-ureteroscopy (m-URS) for treatment of upper ureteral stones in children: A new, different approach. Turk J Urol 2021; 47(3): 248-9.